Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-22-001129
Accepted
2022-04-29 00:15:11
Documents
1
Effectiveness Date
2022-04-28
Registration Form
POS AM
Reference AccNo
0001193125-22-061620

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 608
  Complete submission text file 9999999995-22-001129.txt   1678
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

EIN.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-253539 | Film No.: 22869767
SIC: 2834 Pharmaceutical Preparations